Can Xometry (XMTR) Justify Its Price Through Future Cash Flow?

Xometry has been on a striking run in recent years, which naturally raises a simple question for you as a shareholder or potential buyer. Is the current share price grounded in the cash the business can generate over time, or is the market getting ahead of those cash flows?

• Over the past 3 years the stock has delivered a very large gain, which puts a lot of weight on whether the underlying cash generation can support that kind of share price journey.
• The expanded TradeCentric partnership, which adds automation tools to Xometry's marketplace, may support expectations for smoother procurement and potentially more efficient cash collection and spending over time.
• What if you looked at Xometry through its sales instead? See why Xometry's 7.1x P/S tells a different valuation story.

For investors, the debate is whether today's valuation for Xometry is adequately backed by the cash flows implied by its current business model.

If you want a benchmark while weighing Xometry's cash flow story, it can help to compare it with 31 high quality undervalued stocks.

Where Does Xometry Sit on Cash Flow?

The Discounted Cash Flow, or DCF, model here focuses on the cash Xometry can generate for shareholders over time. Latest twelve month free cash flow sits at a loss of $6.95m, so the framework leans heavily on the view that the marketplace can shift from cash burn to positive contributions over the coming years.

The longer term projections assume recovering and then growing free cash flow, with forecast figures in the hundreds of millions of dollars by the early 2030s, which has a big influence on why the DCF output sits broadly in line with the current $100.57 share price. The expanded TradeCentric integration, which targets smoother purchasing and invoicing, helps explain why the market is comfortable paying up today for a business that is still working through cash losses. If you want to see how that stacks up against other opportunities, you can compare this valuation with 31 high quality undervalued stocks before deciding whether Xometry's cash flow profile justifies the current tag. Find out what Xometry could be worth using our Discounted Cash Flow (DCF) estimate.

The Xometry Narrative: What Would Justify Today's Price?

Narratives on Xometry sit on Simply Wall St's Community page and pick up where the valuation question leaves off by spelling out which assumptions about future growth, margins and earnings would need to play out for the share price to be worth materially more or materially less than it is today. Rather than boiling everything down to a single multiple or DCF output, each narrative lays out the specific drivers behind its fair value so you can compare those expectations with the results as they are reported.

Community views on Xometry split between those who see AI led marketplace execution as underappreciated and those who think expectations already stretch the story.

Bull case: 8% undervalued

"Xometry's growing network effect, evidenced by its expanding base of buyers and suppliers and increasing share of larger enterprise accounts, is enhancing marketplace liquidity and pricing power..."

Discover why this Narrative puts Xometry at 8% undervalued.

Bear case: 6% overvalued

"If the Siemens integration into CAD and PLM workflows underdelivers or is slower to roll out globally than expected, the uplift in active buyers and order volumes could be far below what current expectations imply..."

Explore why this Narrative puts Xometry at 6% overvalued.

Xometry’s valuation still leaves one crucial issue unresolved

Pricing the future cash story is only part of the picture, because Simply Wall St’s broader checks have also highlighted specific concerns that investors may want to weigh for Xometry before getting comfortable with the stock’s profile. Take a closer look at 1 warning sign before settling on a valuation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com